How big is the Vascular Endothelial Growth Factors Inhibitors Market?

The Vascular Endothelial Growth Factors Inhibitors Market size is expected to reach USD 13.80 billion in 2024 and grow at a CAGR of 5.80% to reach USD 18.30 billion by 2029. Read More

What is the current Vascular Endothelial Growth Factors Inhibitors Market size?

In 2024, the Vascular Endothelial Growth Factors Inhibitors Market size is expected to reach USD 13.80 billion. Read More

Who are the key players in Vascular Endothelial Growth Factors Inhibitors Market?

F. Hoffmann-La Roche Ltd, Astrazeneca, Regeneron Pharmaceuticals Inc., Novartis AG and Xbrane Biopharma AB are the major companies operating in the Vascular Endothelial Growth Factors Inhibitors Market. Read More

Which is the fastest growing region in Vascular Endothelial Growth Factors Inhibitors Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Vascular Endothelial Growth Factors Inhibitors Market?

In 2024, the North America accounts for the largest market share in Vascular Endothelial Growth Factors Inhibitors Market. Read More

What years does this Vascular Endothelial Growth Factors Inhibitors Market cover, and what was the market size in 2023?

In 2023, the Vascular Endothelial Growth Factors Inhibitors Market size was estimated at USD 13.00 billion. The report covers the Vascular Endothelial Growth Factors Inhibitors Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vascular Endothelial Growth Factors Inhibitors Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vascular Endothelial Growth Factors (VEGF) Inhibitors Market Share

Statistics for the 2023 & 2024 Vascular Endothelial Growth Factors (VEGF) Inhibitors market share, created by Mordor Intelligence™ Industry Reports. Vascular Endothelial Growth Factors (VEGF) Inhibitors share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Vascular Endothelial Growth Factors (VEGF) Inhibitors Industry

The market for VEGF inhibitors is highly competitive, with established and new entrants competing for market share, innovation, patent expirations, and unmet needs, which are key drivers shaping the future of this market. The major players in the market include F. Hoffmann-La Roche Ltd, AstraZeneca, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals In, Bayer AG, Novartis AG, Merck KGaA, Pfizer Inc., Xbrane Biopharma AB, among others.